CRA provided testimony on behalf of plaintiff in litigation regarding a health plan’s use of MFN clauses with hospitals. CRA identified several mechanisms by which the MFN clauses were likely to reduce competition in this matter and demonstrated that they had historically harmed competitors. CRA also analyzed whether this harm to competition was offset by the procompetitive effects of MFN clauses.
CRA earns widespread recognition across biggest competition cases for GCR Awards 2026
Charles River Associates achieved widespread recognition at the 2026 Global Competition Review Awards, with nominations spanning nearly every major competition